Welcome to the Australian Metaplastic Breast Cancer Community
Welcome to Australia
Australia is a wild and beautiful place, a colourful land of bright reds and oranges of the outback sands and vibrant greens and blues of the reefs, rainforests and beaches that surround modern cities and expressive indigenous culture.
Australia is a land like no other, with about one million different native species. More than 80 per cent of the country’s flowering plants, mammals, reptiles and frogs are unique to Australia, along with most of its freshwater fish and almost half of its birds.
The geographic isolation here has meant that much of its flora and fauna is very different from species in other parts of the world. Most are found nowhere else. However, some closely related species are found on the continents which once made up the ancient southern supercontinent Gondwana.
Australia’s population is almost 25 million and concentrated along the coast region from Cairns to Adelaide, with another concentration around Perth in Western Australia. The centre of Australia is sparsely populated and around 75% of the continent is either completely arid or semi-arid.
Investments have been made in many kinds of social infrastructure including health and education. Research is a defining characteristic of Australia’s Universities and Hospitals. For decades, Australian universities have delivered excellence in research and innovation and have advanced a research culture and system that has been responsible for world-leading breakthroughs. In many cases, these successes were collaborative research efforts both domestically and internationally.
International research collaborations are a mechanism for knowledge exchange, creating positive impacts throughout the broader community.
The more we engage globally the more we prosper.

Australian Metaplastic Breast Cancer Global Representatives
Contacts:
Susie Ireland EMAIL

- Helpful Information
- Clinical Trial & Research
- Additional Support & Resources
- Facebook GroupsTab Title
- Prognostic features of Metaplastic Breast Cancer
- Glossary of Terms
- Lumpectomy vs Mastectomy – May2024
- MpBC Current Understandings & Future Directions
- Common MpBC Genetic Mutations – ESMO 2024
- Genetic Testing
- OncoType Testing Info
- Genomic Testing – ctDNA Liquid Biopsy
- The BRCAs – NHS Foundation Trust, Corso et al
- Neoadjuvant therapy TN MpBC- Xi’an Jiaotong Univ.
- Chemotherapy Guide (the dos and don’ts)
- White Blood Count Booster (Pegfilgrastim) Tips
- Immunotherapy Guide
- Immunotherapy Related Adrenal Crisis
- Tackling Chemo Resistant Breast Cancer
- Pathological Complete Response Study (2023)
- TNBC Treatment (we are often treated as TNBC)
- Keynote 522 Treatment (Stage 2+)
- Keytruda Quality of Life Study
- Precision Oncology – ESMO 2025
- Complimentary Therapies
- Xeloda (Capecitabine) Guide
- DPD Deficiency (taking Xeloda or Fluorouracil info)
- Predicting MpBC Survival (2023)
- APODDC on Genomic Testing /NG Sequencing
- Do you need 3D mammos, MRI, ultrasounds?
- Living with Breast Cancer
- MpBC Follow Up Care
- Clinical Trials Search Australia
- Australia New Zealand Clinical Trial Registry
- Victoria Specific Clinical Trial Search
- Keynote 522 Trial Info – Jan2024
- Hope and Hype (several Trials) – Brussels
- Residual Cancer Burden (RCB) Explained /iSPY2
- Residual Cancer Burden Calculator
- ReDo Trials (off label drugs) Info / USA Database
- MpBC vs IDC Study / Sungkyunkwan University, Korea
- CDDD11-8 CDK9 inhibitor pre clinical trial
- Metastatic TNBC Clinical Trial podcast 2025
- Paxalisib – (PI3K) pathway inhibitor trial Jan2025
- MpBC Osteosarcomatous Differentiation Case- 2022
- MpBC Carcinosarcoma Case Study 2022
- Rare Cancer Australia
- Breast Cancer Network Australia
- Cancer Council Australia
- Australian Breast Cancer .org Research
- Breast Cancer Foundation New Zealand
- Familial Cancer Center
- Caring for Someone with Cancer
- TNBC Hub
- Financial Aid
- Wig Aid ( Australia) and here
- Wig Aid (New Zealand) and here
- Transportation to Chemo Help
- McGrath Foundation Support
- Think Pink
- Cancer Contact List of Organizations
- Metaplastic Breast Cancer Global Alliance
- Metaplastic Breast Cancer
- Metaplastic Breast Cancer Support & Information
- Immunotherapy/ Keytruda Support Group
- Adrenal Insufficiency United (immunotherapy related)
- Ladies with Adrenal Insufficiency ONLY
- Troldevy Stage 4 Support Group
- Xeloda (Capecitabine) Support Group
- Lynparza Support Group
- TNBC Stage 4 Women’s Only Group
Australian Healthcare
Medicare is the scheme that gives Australian residents access to healthcare. Most taxpayers pay a Medicare Levy of 2% of their taxable income to help fund it. Medicare gives you access to free or subsidised treatment by health professionals such as doctors, specialists, optometrists, dentists and other allied health practitioners (in special circumstances only), with free treatment and accommodation as a public (Medicare) patient in a public hospital. Medicare also provides 75% of the Medicare Schedule fee for services and procedures if you are a private patient in a public or private hospital (not including hospital accommodation and items such as theatre fees and medicines).
Medicare also provides limited benefits if you are covered by a Reciprocal Health Care Agreement with another country. These countries are United Kingdom, Sweden, the Netherlands, Finland, Norway, Malta, Italy, Belgium, the Republic of Ireland and New Zealand. New RHCA may be negotiated at any time.
Knowledgeable Doctors : Researchers
For more information on individual knowledgeable doctors listed below, please click the link for the website
associated with the knowledgeable doctor you are interested in learning more about.
* Indicates a member of the MpBC Global Alliance’s Medical/Scientific Advisory Board
Name | Address | Location | Phone Number | Website | Researching |
---|---|---|---|---|---|
Dr Priyakshi Kalita de Croft | Postdoctoral Research Scientist UQ Centre for Clinical Research Faculty of Medicine Queensland, Australia |
Queensland, Australia |
+61 7 334 66048 | HERE | Publications |
Dr Jamie Kutasovic | Postdoctoral Research Scientist UQ Centre for Clinical Research Faculty of Medicine Queensland, Australia |
Queensland, Australia |
+61 7 334 66048 | HERE | Publications |
Professor Sunil Lakhani * | Head, Discipline of Pathology UQ Centre for Clinical Research Faculty of Medicine Queensland, Australia |
Queensland, Australia |
+61 7 334 66052 | HERE | Editor for the WHO Tumor Classification Books of the Breast Publications |
Dr Amy McCart Reed * | Postdoctoral Research Scientist UQ Centre for Clinical Research Faculty of Medicine The University of Queensland |
Queensland, Australia | Tel: +61 7 334 66030 | HERE | Aggressive Breast Cancer Genomics Publications |
Associate Professor Marina Reeves | Associate Professor School of Public Health The University of Queensland Queensland, Australia |
Queensland, Australia |
+61 7 334 64692 | HERE | Publications |
Professor Matt Trau | Director, Centre for Personalised Nanomedicine Professor of Chemistry, School of Chemistry & Molecular Biosciences Australian Institute for Bioengineering & Nanotechnology (AIBN) The University of QueenslandMailing Address: AIBN, The University of Queensland, ST LUCIA, QLD 4072 Australia. Physical Address: Building 75 – Cnr of College and Cooper Road. |
Queensland, Australia | Tel: +61 7 3346 4173 Fax: +61 7 3346 3973 |
HERE | Nanotechnology and Co-founder of the Australian Institute for Bioengineering Publications |
Stand Up and Be Counted in the Fight Against
Metaplastic Breast Cancer!
Click HERE to See Location of Diagnosed Members in Australia
Videos
Prof Matt Trau is an eminent National Breast Cancer Funded Researcher. He is Prof of Chemistry at the University of Queensland and Deputy Director & Co Founder of Australian Institute for Bio Engineering and Nano Technology. Prof Trau is an internationally recognised leader in the area of Chemistry, Nano technology, Biology & Medicine – all key to identifying new approaches to addressing problems in Breast Cancer Research. Prof Trau is also currently the lead investigator on a 5 Yr National Collaborative Research Program for the National Breast Cancer Foundation.
Link to Xing Technology Facebook page
Dr Amy McCart Reed
I am a cancer genomics and molecular pathology specialist, with a primary focus on breast cancer. I am passionate about precision medicine and biobanking, and effective community engagement in health and medical research. In addition to my breast cancer research portfolio, I co-manage the Brisbane Breast Bank and the Brisbane node of the BROCADE rapid autopsy study.